Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Salvianolic Acid B Inhibits Activation of Human Primary Hepatic Stellate Cells Through Downregulation of the Myocyte Enhancer Factor 2 Signaling Pathway.

Authors:
Wenwei Zhang Jian Ping Yang Zhou Gaofeng Chen Lieming Xu

Front Pharmacol 2019 11;10:322. Epub 2019 Apr 11.

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Various isoforms of myocyte enhancer factor 2 (MEF2) have been shown to play a role in the activation of rat hepatic stellate cells (HSCs) in culture. The signals that regulate MEF2 in HSCs are unknown. In addition, whether MEF2s regulate the activation of human HSCs (H-HSCs) is unclear. Here, we studied the expression and function of MEF2s in H-HSCs. Our data showed that the levels of MEF2A, C, and D proteins were high in liver tissues from patients with cirrhosis and increased during culture-induced activation of primary H-HSCs. Exposure of H-HSCs to transforming growth factor beta 1 (TGF-β1) led to a significant increase in MEF2A and C protein levels and enhanced MEF2 activity. Interestingly, TGF-β1 did not further enhance MEF2D levels. Furthermore, TGF-β1 activated p38 mitogen-activated protein kinase (MAPK) and led to increased phosphorylation of MEF2C at its p38 recognition site. Inhibition of p38 MAPK inhibited both TGF-β1- and culture-induced activation of MEF2. The activity of collagen I reporter in H-HSCs was significantly reduced when MEF2A and MEF2C were blocked with overexpression of dominant negative MEF2 mutants. Salvianolic-acid B (SA-B), a water-soluble element of known to have anti-fibrosis effects, attenuated both basal and TGF-β1-induced increased levels of MEF2A and C mRNA and protein. In addition, SA-B inhibited MEF2 activity, which correlated with reduced expression of the HSC activation markers, α-smooth muscle actin (α-SMA), and collagen I. Administration of SA-B reduced MEF2A , which was accompanied by reduced levels of α-SMA in a model of dimethylnitrosamine-induced rat liver fibrosis. We concluded that the MEF2 transcription factor was stimulated by TGF-β1 in H-HSCs. Antagonizing TGF-β1-induced activation of the MEF2 signaling pathway may account in part for the anti-fibrosis effects of SA-B.

Download full-text PDF

 Source
http://dx.doi.org/10.3389/fphar.2019.00322DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470251PMC
April 2019

Publication Analysis

Top Keywords

mef2 activity
12
enhancer factor
8
myocyte enhancer
8
anti-fibrosis effects
8
stellate cells
8
reduced mef2a
8
culture-induced activation
8
levels mef2a
8
hepatic stellate
8
signaling pathway
8
activation mef2
8
activation human
8
mef2
7
activation
7
h-hscs
6
levels
5
mef2a
5
mitogen-activated protein
4
activity correlated
4
p38 mitogen-activated
4

Keyword Occurance

Similar Publications

Mechanistic insights into the CYP2C19 genetic variants prevalent in the Indian population.

Authors:
Shaik Mohammad Naushad Kiran Kumar Vattam Yadamreddy Kanaka Durga Devi Tajamul Hussain Salman Alrokayan Vijay Kumar Kutala

Gene 2021 Mar 23;784:145592. Epub 2021 Mar 23.

Department of Clinical Pharmacology and Therapeutics, Nizam's Institute of Medical Sciences, Hyderabad, India. Electronic address:

Purpose: CYP2C19 metabolizes the antiplatelet and antiepileptic drugs. Any alteration in CYP2C19 activity might influence the therapeutic efficacy. The objective of this study was to identify CYP2C19 variants prevalent in Indians and perform their in silico characterization. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes.

Authors:
Kathryn G Helmstadter Senka Ljubojevic-Holzer Brent M Wood Khanha D Taheri Simon Sedej Jeffrey R Erickson Julie Bossuyt Donald M Bers

Basic Res Cardiol 2021 Feb 15;116(1):11. Epub 2021 Feb 15.

Department of Pharmacology, University of California, Genome Building Rm 3513, Davis, CA, 95616-8636, USA.

Nuclear histone deacetylase 4 (HDAC4) represses MEF2-mediated transcription, implicated in the development of heart failure. CaMKII-dependent phosphorylation drives nucleus-to-cytoplasm HDAC4 shuttling, but protein kinase A (PKA) is also linked to HDAC4 translocation. However, the interplay of CaMKII and PKA in regulating adult cardiomyocyte HDAC4 translocation is unclear. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes.

Authors:
Angela Nebbioso Fabio Manzo Marco Miceli Mariarosaria Conte Lucrezia Manente Alfonso Baldi Antonio De Luca Dante Rotili Sergio Valente Antonello Mai Alessandro Usiello Hinrich Gronemeyer Lucia Altucci

EMBO Rep 2020 Dec 26;21(12):e51028. Epub 2020 Nov 26.

View Article and Full-Text PDF
December 2020
Similar Publications

The Hox Transcription Factor Ubx Ensures Somatic Myogenesis by Suppressing the Mesodermal Master Regulator Twist.

Authors:
Katrin Domsch Julia Schröder Matthias Janeschik Christoph Schaub Ingrid Lohmann

Cell Rep 2021 Jan;34(1):108577

Heidelberg University, Centre for Organismal Studies (COS) Heidelberg, 69120 Heidelberg, Germany.

Early lineage-specific master regulators are essential for the specification of cell types. However, once cells are committed to a specific fate, it is critical to restrict the activity of such factors to enable differentiation. To date, it remains unclear how these factors are silenced. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy.

Authors:
Changbing Wang Yu Xia Shaochuan Huo Diwen Shou Qing Mei Wenjuan Tang Yinghua Li Hongsheng Liu Yongjian Zhou Bing Zhu

Int J Nanomedicine 2020 4;15:9759-9770. Epub 2020 Dec 4.

Central Laboratory, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510120, People's Republic of China.

Background: Delivery of therapeutic small interfering RNA (siRNA) via functionalized nanoparticles holds great promise for cancer therapy. However, developing a safe and efficient delivery carrier of siRNA is a challenging issue.

Methods: RGDfC peptide was used to modify the surface of selenium nanoparticles (SeNPs) to synthesize a biocompatible siRNA delivery vehicle (R-SeNPs), and MEF2D-siRNA was loaded onto R-SeNPs to prepare a functionalized selenium nanoparticle R-Se@MEF2D-siRNA. Read More

View Article and Full-Text PDF
December 2020
Similar Publications